Ambion, a unit of Applied Biosystems, has recently introduced a new Anti-miR microRNA inhibitor positive control for hsa-let-7c.
According to the company, the validated positive control can be monitored in human or mouse cells by qRT-PCR using a TaqMan gene expression assay to HGMA2.
Ambion has also released sets of its Silencer Select siRNAs targeting the human druggable genome in sets grouped by gene target class. The siRNAs are available in a ready-to-ship 0.25 nanomolar format or in larger customer quantities.